A Phase I Randomized Trial of Topical Insulin for Glaucoma: Safety and Efficacy Outcomes
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Tasneem Khatib (ORCID: https://orcid.org/0000-0001-6576-451X)
- Mariana Nuñez
- Adriana Di Polo (ORCID: https://orcid.org/0000-0003-1430-0760)
- Gala Beykin (ORCID: https://orcid.org/0000-0003-2025-545X)
- Jeffrey L. Goldberg (ORCID: https://orcid.org/0000-0002-1390-7360)
- Qianqian Wang (ORCID: https://orcid.org/0000-0001-8674-6994)
- Zachary Wennberg-Smith
- Mariella Saludares
Institutions
- Stanford Medicine (US)
- Université de Montréal (CA)
- Stanford University (US)
Publication Details
- Journal
- Ophthalmology Science
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1016/j.xops.2025.101032
- Citations
- 1
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- Research to Prevent Blindness